Home › Funds › Casdin Capital › SRPT
Casdin Capital position in SRPT
SAREPTA THERAPEUTICS INC · Health Care
Latest position (Q2 2026)470.00K sh
Reported value held$8.45M
Portfolio Weight0.42%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.10M | $101.73M | New |
| Q4 2021 | 1.35M | $121.57M | Add |
| Q1 2022 | 800.00K | $62.50M | Reduce |
| Q2 2022 | 650.00K | $48.72M | Reduce |
| Q3 2022 | 1.23M | $135.41M | Add |
| Q4 2022 | 1.31M | $170.40M | Add |
| Q1 2023 | 1.19M | $163.33M | Reduce |
| Q2 2023 | 1.01M | $116.24M | Reduce |
| Q3 2023 | 1.01M | $122.47M | Hold |
| Q4 2023 | 1.01M | $97.06M | Hold |
| Q1 2024 | 1.07M | $138.39M | Add |
| Q2 2024 | 1.07M | $169.61M | Hold |
| Q3 2024 | 1.07M | $134.07M | Hold |
| Q4 2024 | 1.07M | $130.53M | Hold |
| Q1 2025 | 900.78K | $57.49M | Reduce |
| Q2 2025 | 990.10K | $16.93M | Add |
| Q2 2026 | 470.00K | $8.45M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SRPT
- BlackRock Inc 18.99M sh · $341.34M · Q2 2026
- Vanguard Group 11.81M sh · $254.17M · Q4 2025
- Two Sigma Investments 4.60M sh · $82.64M · Q2 2026
- AQR Capital Management 4.33M sh · $76.87M · Q2 2026
- Geode Capital Management 2.77M sh · $49.82M · Q2 2026
- Marshall Wace 2.21M sh · $39.64M · Q2 2026
- Morgan Stanley 2.20M sh · $39.58M · Q2 2026
- Bank of America Corp 2.06M sh · $36.95M · Q2 2026
- Goldman Sachs Group 2.04M sh · $36.70M · Q2 2026
- Citadel Advisors 1.54M sh · $27.75M · Q2 2026
- Northern Trust Corp 1.21M sh · $21.76M · Q2 2026
- Millennium Management 1.19M sh · $21.45M · Q2 2026